Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
14.86
-0.14 (-0.93%)
At close: Nov 6, 2026, 4:00 PM EST
14.82
-0.04 (-0.27%)
After-hours: Nov 6, 2026, 7:46 PM EST
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $365.34 million as of November 6, 2026. It is the 16,453rd most valuable company in the world and the 2,963rd biggest in the United States. Its market cap has increased by 14.98% in one year.
Market Cap
365.34M
Enterprise Value
215.64M
1-Year Change
14.98%
Global Rank
Country Rank
#2,963 United States
Category
ChartMarket Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $365.34M, a decrease of -91.15%. That is a compound annual growth rate of -36.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 365.34M | -44.13% |
| Dec 31, 2025 | 653.89M | 249.70% |
| Dec 31, 2024 | 186.98M | -61.73% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
| Jun 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BlossomHill Therapeutics | 388.41M |
| Zura Bio | 387.71M |
| C4 Therapeutics | 383.22M |
| Avalo Therapeutics | 379.16M |
| MapLight Therapeutics | 372.64M |
| Contineum Therapeutics | 367.93M |
| Autolus Therapeutics | 365.97M |
| Orchestra BioMed Holdings | 361.83M |